Numinus Wellness brings on five new executives to help support growth across Health, R&D and Bioscience divisions Numinus told shareholders that the new team will support its aim to expand its clinic network internationally, develop and market psychedelic-assisted psychotherapies and boost laboratory capabilities Numinus is the first public company in Canada to receive a licence to produce and extract psilocybin from mushrooms Numinus Wellness Inc (CVE:NUMI) has announced a series of new hires at the leadership table. The psychedelics firm has brought on five new executives to sup...